Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | ACP3 | P15309 | 1/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.39 |
| ▸ | ADRA2B | P18089 | 3/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 3/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.39 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26212 | 0.82 | CYP1A2 (0.58) | CYP1A2CYP2C19CYP2C9ALDH1A1MAPT | |
| SCHEMBL477544 | 0.81 | PDCD1 (0.47) | CYP1A2CYP2C19CYP2C9ALDH1A1MAPT | |
| SCHEMBL27896460 | 0.79 | DPP4 (0.53) | CYP1A2CYP2C19CYP2C9ALDH1A1MAPT | |
| SCHEMBL2992860 | 0.79 | MEN1 (0.49) | CYP1A2CYP2C19CYP2C9ALDH1A1MAPT | |
| SCHEMBL31517086 | 0.79 | CYP1A2 (0.45) | CYP1A2CYP2C19CYP2C9ALDH1A1MAPT | |
| SCHEMBL4438778 | 0.79 | CYP1A2 (0.45) | CYP1A2CYP2C19CYP2C9ALDH1A1MAPT | |
| SCHEMBL3101185 | 0.79 | CYP1A2 (0.45) | CYP1A2CYP2C19CYP2C9ALDH1A1MAPT | |
| SCHEMBL11650416 | 0.79 | CYP1A2 (0.45) | CYP1A2CYP2C19CYP2C9ALDH1A1MAPT | |
| SCHEMBL9300875 | 0.79 | CYP1A2 (0.45) | CYP1A2CYP2C19CYP2C9ALDH1A1MAPT | |
| SCHEMBL25302086 | 0.79 | ALDH1A1 (0.59) | CYP1A2ALDH1A1MAPTHPGDTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4530 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112055711-B | Cyclohexylic acid triazolazine as LPA antagonist | 百时美施贵宝公司 | 2024-07-23 | — | — | CN | disclosed |
| WO-2024151257-A1 | NUCLEOTIDE EXTENSION CHAIN VERIFICATION | AGILENT TECHNOLOGIES, INC. (US) | 2024-07-18 | — | — | WO | disclosed |
| US-20240240229-A1 | METHODS OF ADMINISTERING MONOMETHYL FUMARATE AND PRODRUGS THEREOF HAVING REDUCED SIDE EFFECTS | HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT | 2024-07-18 | — | — | US | disclosed |
| US-12037357-B2 | Compounds for activating invariant natural killer T-cells and methods of use in eliminating inflammatory senescent cells | DECIDUOUS THERAPEUTICS, INC. (US) | 2024-07-16 | — | — | US | disclosed |
| CN-112689634-B | SMAD3 inhibitors | 莫扎制药有限公司 | 2024-07-16 | — | — | CN | disclosed |
| US-12037340-B2 | Pentacyclic derivatives as Zika virus inhibitors | GILEAD SCIENCES, INC. (US) | 2024-07-16 | — | — | US | disclosed |
| CN-118355029-A | Methods of treating diffuse large B-cell lymphomas using anti-CD 79B immunoconjugates | 基因泰克公司 | 2024-07-16 | — | — | CN | disclosed |
| US-12037415-B2 | Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient | YUYU PHARMA, INC. (KR) | 2024-07-16 | — | — | US | disclosed |
| US-20240229126-A1 | NUCLEOTIDE EXTENSION CHAIN VERIFICATION | AGILENT TECHNOLOGIES, INC. | 2024-07-11 | — | — | US | disclosed |
| US-20240228444-A1 | HETEROCYCLIC COMPOUNDS AND RELATED METHODS | RECURSION PHARMACEUTICALS, INC. | 2024-07-11 | — | — | US | disclosed |
| WO-2002005837-A1 | ANTIMICROBIAL SULFONAMIDE DERIVATIVES OF LIPOPEPTIDE ANTIBIOTICS | INTRABIOTICS PHARMACEUTICALS, INC. (US) | 2002-01-24 | — | — | WO | disclosed |
| WO-2002005838-A1 | DERIVATIVES OF LASPARTOMYCIN AND PREPARATION AND USE THEREOF | INTRABIOTICS PHARMACEUTICALS, INC. (US) | 2002-01-24 | — | — | WO | disclosed |
| WO-2001091758-A1 | WATER-SOLUBLE AMIDE DERIVATIVES OF POLYENE MACROLIDES AND PREPARATION AND USES THEREOF | INTRABIOTICS PHARMACEUTICALS, INC. (US) | 2001-12-06 | — | — | WO | disclosed |
| EP-1141137-A1 | WATER-SOLUBLE RHODAMINE DYES AND CONJUGATES THEREOF | Applera Corporation (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2001049790-A2 | MOBILITY-MODIFYING CYANINE DYES | APPLERA CORPORATION (US) | 2001-07-12 | — | — | WO | disclosed |
| US-20010007905-A1 | Extended rhodamine dye compound suitable for the creating of sets of spactrally resolvable fluorescent labels particlularly useful for fluorescence based DNA sequencing system | THE PERKIN-ELMER CORPORATION | 2001-07-12 | — | — | US | disclosed |
| US-6248884-B1 | PARTICULARLY WELL SUITED FOR USE IN AUTOMATED FLUORESCENCE-BASED DNA SEQUENCING SYSTEMS USING AN EXCITATION LIGHT SOURCE HAVING A WAVELENGTH GREATER THAN ABOUT 630 NM, E.G., A HELIUM-NEON GAS LASER OR A SOLID STATE DIODE LASER. | THE PERKIN-ELMER CORPORATION | 2001-06-19 | — | — | US | disclosed |
| WO-2001032783-A1 | WATER-SOLUBLE RHODAMINE DYES AND CONJUGATES THEREOF | APPLERA CORPORATION (US) | 2001-05-10 | — | — | WO | disclosed |
| US-6191278-B1 | COMPRISING A RHODAMINE-TYPE PARENT RING HAVING ATTACHED TO THE XANTHENE C9 CARBON A PHENYL GROUP THAT IS SUBSTITUTED WITH CARBOXY OR SULFONATE GROUP, ONE TO THREE AMINOPYRIDINIUM GROUPS AND AN ALKYL- OR ARYLTHIO, AND OPTIONALLY OTHER GROUPS | PE CORPORATION | 2001-02-20 | — | — | US | disclosed |
| WO-2000075236-A1 | EXTENDED RHODAMINE COMPOUNDS USEFUL AS FLUORESCENT LABELS | PE CORPORATION (NY) (US) | 2000-12-14 | — | — | WO | disclosed |